P

Inventor

KWON BYOUNG S

KR28 patents
⚠️ This page may combine multiple inventors who share the name “KWON BYOUNG S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EUTILEX CO LTD

20 patents
US10174122B2Jan 8, 2019

Anti-human 4-1BB antibodies and uses thereof

EUTILEX CO LTD23 citations92
US10919972B2Feb 16, 2021

Anti-human 4-1BB antibodies and uses thereof

EUTILEX CO LTD1 citations71
US10774151B2Sep 15, 2020

Anti-human 4-1BB antibodies and uses thereof

EUTILEX CO LTD1 citations71
US10626183B2Apr 21, 2020

IFN-γ-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof

EUTILEX CO LTD2 citations71
US10233254B2Mar 19, 2019

Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof

EUTILEX CO LTD4 citations70
US11013765B2May 25, 2021

Chimeric antigen receptor that binds HLA-DR and CAR-T cell

EUTILEX CO LTD2 citations68
US11072646B2Jul 27, 2021

Epitope for switching to TH1 cell and use thereof

EUTILEX CO LTD0 citations62
US11053298B2Jul 6, 2021

Epitope for switching to TH2 cell and use thereof

EUTILEX CO LTD0 citations62
US12559538B2Feb 24, 2026

PD-1 polypeptide variants

EUTILEX CO LTD0 citations61
US11859004B2Jan 2, 2024

Anti-human 4-1BB antibodies and uses thereof

EUTILEX CO LTD0 citations61
US10919976B2Feb 16, 2021

IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof

EUTILEX CO LTD1 citations61
US10801011B2Oct 13, 2020

Methods for isolating and proliferating autologous cancer antigen-specific CD8+ T cells

EUTILEX CO LTD1 citations59
US10570371B2Feb 25, 2020

Methods for isolating and proliferating autologous cancer antigen-specific CD8+T cells

EUTILEX CO LTD1 citations59
US11905334B2Feb 20, 2024

Anti-human VSIG4 antibodies and uses thereof

EUTILEX CO LTD0 citations58
US10927183B2Feb 23, 2021

Anti-human VSIG4 antibodies and uses thereof

EUTILEX CO LTD1 citations58
US12331116B2Jun 17, 2025

Bispecific epitope binding protein comprising anti-4-1BB antibody and a PD-1 protein or fragments thereof and use thereof

EUTILEX CO LTD0 citations57
US11951130B2Apr 9, 2024

Chimeric antigen receptor that binds HLA-DR and CAR-T cell

EUTILEX CO LTD0 citations57
US10851151B2Dec 1, 2020

Epitope for switching to TH17 cell and use thereof

EUTILEX CO LTD0 citations52
US12122845B2Oct 22, 2024

Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof

EUTILEX CO LTD0 citations47
US11395836B2Jul 26, 2022

Cancer antigen specific cytotoxic T cell

EUTILEX CO LTD0 citations46

UNIV INDIANA RES & TECH CORP

2 patents

ADVANCED RES & TECH INST

2 patents

(unassigned)

1 patent

ADVANCED RES AND TECHNOLOGY

1 patent

DONALD GUTHRIE FOUNDATION FOR

1 patent

GREEN CROSS KOREA

1 patent